BPC-157 Dosage Guide for Research
This guide provides researchers with dosage reference information for BPC-157 (Body Protection Compound-157), one of the most studied healing peptides. Dosing data is compiled from published preclinical research studies.
Research Dosage Range
In published preclinical research, BPC-157 has been studied across a wide dosage range:
| Application | Dose Range | Route | Frequency |
|---|---|---|---|
| Standard research dose | 200-300 mcg/day | Subcutaneous | Once daily |
| Low dose protocol | 100-200 mcg/day | Subcutaneous | Once daily |
| Higher dose protocol | 300-500 mcg/day | Subcutaneous | Once daily |
| Oral research | 250-500 mcg/day | Oral | Once daily |
Note: The most commonly referenced research dose is 250 mcg (0.25 mg) once daily via subcutaneous injection.
Reconstitution Guide
Use bacteriostatic water for reconstitution. See our complete reconstitution guide.
Concentration Table (5mg Vial)
| BAC Water | Concentration | 200mcg Dose | 250mcg Dose | 300mcg Dose | 500mcg Dose |
|---|---|---|---|---|---|
| 1.0 mL | 5,000 mcg/mL | 4 units | 5 units | 6 units | 10 units |
| 2.0 mL | 2,500 mcg/mL | 8 units | 10 units | 12 units | 20 units |
| 2.5 mL | 2,000 mcg/mL | 10 units | 12.5 units | 15 units | 25 units |
Recommended: Add 2.0 mL BAC water to a 5mg vial for the most practical concentration (2,500 mcg/mL). At this concentration, 10 units = 250 mcg.
Vial Duration Calculator
| Vial Size | Daily Dose | Days Per Vial |
|---|---|---|
| 5 mg | 250 mcg | 20 days |
| 5 mg | 500 mcg | 10 days |
| 10 mg | 250 mcg | 40 days |
| 10 mg | 500 mcg | 20 days |
Research Protocol Duration
Published studies have used BPC-157 across varying durations:
- Acute injury models: 7-14 days
- Standard research protocols: 4-8 weeks
- Extended protocols: 8-12 weeks
- Chronic models: 12+ weeks
Most preclinical research uses a 4-week protocol as the standard baseline.
Administration Methods
Subcutaneous Injection
The most common research route. Inject subcutaneously near the area of interest or in standard injection sites (abdomen, thigh). BPC-157 exhibits systemic distribution regardless of injection site.
Oral Administration
BPC-157’s unique gastric acid stability makes oral delivery viable. Oral BPC-157 tablets (500mg x 100 tabs) are available for oral administration research. See our oral vs injectable comparison.
Combination Protocols
BPC-157 is frequently combined with other peptides in research:
- Wolverine Blend (BPC-157 + TB-500): The most popular research combination. See Wolverine Blend guide
- BPC-157 + GHK-Cu: Tissue repair + collagen synthesis. See comparison
Dose Calculation Formula
Volume (mL) = Desired Dose (mcg) ÷ Concentration (mcg/mL)
Example: 250 mcg from 2,500 mcg/mL solution = 0.10 mL = 10 units
Storage After Reconstitution
- Refrigerate at 2-8°C
- Use within 14-21 days
- Protect from light
- Do not freeze reconstituted solution
See our peptide storage guide for comprehensive protocols.
Frequently Asked Questions
What is the most common BPC-157 research dose?
250 mcg (0.25 mg) once daily via subcutaneous injection is the most frequently cited research dose in published literature.
Should BPC-157 be injected locally or systemically?
Research suggests BPC-157 has systemic effects regardless of injection site. However, some protocols inject near the area of research interest for potentially enhanced local concentrations.
How does oral BPC-157 dosing compare to injectable?
Oral doses are typically higher (250-500 mcg) to account for first-pass metabolism, though BPC-157’s gastric acid stability provides unusually high oral bioavailability for a peptide. See our oral vs injectable comparison.
Related Articles
- What is BPC-157?
- BPC-157: Complete Research Guide
- BPC-157 Benefits
- Oral vs Injectable BPC-157
- How to Reconstitute Peptides
All products sold by Proxiva Labs are intended for research and laboratory use only. Not for human consumption.
All products are sold strictly for research purposes only. Not for human consumption.